205 related articles for article (PubMed ID: 30563883)
21. Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia.
Wang J; Wang Z; Wei W; Zhang W; Zhang T; Cheng H; Fei X; Yin Y; Gu J; Yuan L
Biol Blood Marrow Transplant; 2019 Jan; 25(1):121-128. PubMed ID: 30205230
[TBL] [Abstract][Full Text] [Related]
22. HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis.
Meybodi MA; Cao W; Luznik L; Bashey A; Zhang X; Romee R; Saber W; Hamadani M; Weisdorf DJ; Chu H; Rashidi A
Blood Adv; 2019 Sep; 3(17):2581-2585. PubMed ID: 31484635
[TBL] [Abstract][Full Text] [Related]
23. Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
Huo MR; Pei XY; Li D; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ
Bone Marrow Transplant; 2018 May; 53(5):600-608. PubMed ID: 29335631
[TBL] [Abstract][Full Text] [Related]
24. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
25. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.
Piemontese S; Ciceri F; Labopin M; Arcese W; Kyrcz-Krzemien S; Santarone S; Huang H; Beelen D; Gorin NC; Craddock C; Gulbas Z; Bacigalupo A; Mohty M; Nagler A;
J Hematol Oncol; 2017 Jan; 10(1):24. PubMed ID: 28103944
[TBL] [Abstract][Full Text] [Related]
26. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
[TBL] [Abstract][Full Text] [Related]
27. Effect of Donor NKG2D Polymorphism on Relapse after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Ido K; Koh H; Hirose A; Seto T; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Nanno S; Nakamae M; Nishimoto M; Nakashima Y; Hino M; Nakamae H
Transplant Cell Ther; 2022 Jan; 28(1):20.e1-20.e10. PubMed ID: 34607074
[TBL] [Abstract][Full Text] [Related]
28. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
[TBL] [Abstract][Full Text] [Related]
29. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
[TBL] [Abstract][Full Text] [Related]
30. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes.
Kanda J; Ikegame K; Fuji S; Kurokawa M; Kanamori H; Fukuda T; Ohashi K; Ishikawa J; Ogawa H; Inoue M; Ichinohe T; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2031-2037. PubMed ID: 27492794
[TBL] [Abstract][Full Text] [Related]
31. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
[TBL] [Abstract][Full Text] [Related]
32. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Srour SA; Greenbaum U; Carmazzi Y; Rondon G; Ciurea SO; Ma Q; Shpall EJ; Champlin RE; Cao K
Cancer; 2023 Apr; 129(8):1205-1216. PubMed ID: 36738229
[TBL] [Abstract][Full Text] [Related]
33. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
[TBL] [Abstract][Full Text] [Related]
34. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
[TBL] [Abstract][Full Text] [Related]
35. Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.
Jorge AS; Suárez-Lledó M; Pereira A; Gutierrez G; Fernández-Avilés F; Rosiñol L; Llobet N; Solano T; Urbano-Ispízua Á; Rovira M; Martínez C
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1196-1202. PubMed ID: 29410343
[TBL] [Abstract][Full Text] [Related]
36. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.
Crivello P; Arrieta-Bolaños E; He M; Wang T; Fingerson S; Gadalla SM; Paczesny S; Marsh SGE; Lee SJ; Spellman SR; Bolon YT; Fleischhauer K
J Clin Oncol; 2023 May; 41(13):2416-2427. PubMed ID: 36669145
[TBL] [Abstract][Full Text] [Related]
37. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.
Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A
Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
[TBL] [Abstract][Full Text] [Related]
39. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.
Matsuno N; Wake A; Uchida N; Ishiwata K; Araoka H; Takagi S; Tsuji M; Yamamoto H; Kato D; Matsuhashi Y; Seo S; Masuoka K; Miyakoshi S; Makino S; Yoneyama A; Kanda Y; Taniguchi S
Blood; 2009 Aug; 114(8):1689-95. PubMed ID: 19535797
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamide.
Nakagawa D; Shimomura Y; Mitsuyuki S; Kubo T; Nishikubo M; Okada N; Kamijo K; Yamamoto R; Nagai Y; Hiramoto N; Yoshioka S; Yonetani N; Ishikawa T
Int J Hematol; 2023 Sep; 118(3):347-354. PubMed ID: 37468771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
